The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations.


Journal

JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170

Informations de publication

Date de publication:
08 2022
Historique:
entrez: 22 8 2022
pubmed: 23 8 2022
medline: 25 8 2022
Statut: ppublish

Résumé

On February 24, 2022, a war began within the Ukrainian borders. At least 3.0 million Ukrainian inhabitants have already fled the country. Critical infrastructure, including hospitals, has been damaged. Children with cancer were urgently transported to foreign countries, in an effort to minimize interruption of their life-saving treatments. Most adults did not have that option. War breeds cancer-delaying diagnosis, preventing treatment, and increasing risk. We project that a modest delay in care of only 4 months for five prevalent types of cancer will lead to an excess of over 3,600 cancer deaths in the subsequent years. It is critical that we establish plans to mitigate that risk as soon as possible.

Identifiants

pubmed: 35994695
doi: 10.1200/GO.22.00123
pmc: PMC9470147
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2200123

Références

Ecancermedicalscience. 2020 May 08;14:1039
pubmed: 32565892
Global Health. 2018 Nov 23;14(1):116
pubmed: 30470237
Ecancermedicalscience. 2020 Dec 10;14:1153
pubmed: 33574898
Cancer. 2014 Dec 1;120(23):3699-706
pubmed: 25103108
J Epidemiol. 2021 Dec 5;31(12):653-659
pubmed: 32963211
Lancet Oncol. 2020 Aug;21(8):1023-1034
pubmed: 32702310
Lancet Oncol. 2022 Apr;23(4):439
pubmed: 35286846
BMJ. 2020 Nov 4;371:m4087
pubmed: 33148535
Oral Oncol. 2020 Jan;100:104483
pubmed: 31810040
JAMA Oncol. 2022 Jan 1;8(1):69-78
pubmed: 34709356
J Thorac Oncol. 2022 Feb;17(2):214-227
pubmed: 34774792
Radiat Res. 1994 Feb;137(2 Suppl):S17-67
pubmed: 8127952
Int J Cancer. 2006 Sep 15;119(6):1224-35
pubmed: 16628547
J Glob Oncol. 2018 Sep;4:1-12
pubmed: 30241241

Auteurs

Christian Caglevic (C)

Cancer Research Department, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile.
Clinical Trials Unit, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile.

Christian Rolfo (C)

Clinical Research Center for Thoracic Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.

Ignacio Gil-Bazo (I)

Universidad de Navarra, Department of Oncology, Pamplona, Spain.

Andrés Cardona (A)

Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center-CTIC, ONCOLGroup/FICMAC, Bogota, Colombia.

Jorge Sapunar (J)

Cancer Research Department, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile.

Fred R Hirsch (FR)

Center for Thoracic Oncology. Mount Sinai Cancer, Mount Sinai Health System, Icahn School of Medicine, Joe Lowe and Louis Price Professor of Medicine, Tisch Cancer Institute, New York, NY.

David R Gandara (DR)

Center for Experimental Therapeutics in Cancer, UC Davis Comprehensive Cancer Center, Translational and Clinical Research Program, University of Hawaii Cancer Center, International Society of Liquid Biopsy, Sacramento, CA.

Gilberto Morgan (G)

Skåne University Hospital, Department of Oncology, Lund, Sweden.

Silvia Novello (S)

Oncology Department, AOU San Luigi, University of Turin, Turin, Italy.

Marina-Chiara Garassino (MC)

Thoracic Oncology Program, the University of Chicago, Chicago, IL.

Giannis Mountzios (G)

4th Oncology Department and Clinical Trials Unit Henry Dunant Hospital Center, Athens, Greece.

Natasha B Leighl (NB)

Medical Oncology Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, IHPME, Dalla Lana School of Public Health, Toronto, Canada.

Oscar Arrieta (O)

Toracic Oncology Unit, Instituto Nacional de Cancerologia de Mexico, Mexico City, Mexico.

Alfredo Addeo (A)

Oncology department, University Hospital Geneva, Geneva, Switzerland.

Stephen V Liu (SV)

Lombardi Comprehensive Cancer Center of Georgetown University, Washington, DC.

Luis Corrales (L)

Centro de Investigación y Manejo del Cáncer (CIMCA), San José, Costa Rica.

Vivek Subbiah (V)

Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, Medical Oncology Research, MD Anderson Cancer Network, Clinical Center For Targeted Therapy, Division of Pediatrics UT MD Anderson Cancer Center, Houston, TX.

Francisco Aboitiz (F)

Centro Interdisciplinario de Neurociencias, Facultad de Medicina, Pontificia Universidad Católica, Santiago, Chile.

Franz Villarroel-Espindola (F)

Cancer Research Department, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile.

Felipe Reyes-Cosmelli (F)

Clinical Trials Unit, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile.

Ricardo Morales (R)

Cancer Research Department, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile.
Clinical Trials Unit, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile.

Mauricio Mahave (M)

Cancer Research Department, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile.
Clinical Trials Unit, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile.

Luis Raez (L)

Memorial Cancer Institute/Memorial Health Care System, MCIFAU Florida Cancer Center of Excellence, Florida International University, Miami, FL.

Jorge Alatorre (J)

Instituto Nacional de Enfermedades Respiratorias (INER) Clínica de Oncología Torácica, México D.F., Mexico.

Edgardo Santos (E)

Florida Precision Oncology/a Division of Genesis Care USA, Research Services Thoracic and Head/Neck Cancer Programs Clinical, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL.

Luis Ubillos (L)

Instituto Nacional del Cancer, Montevideo, Uruguay.

Daniel S W Tan (DSW)

Department of Medical Oncology, National Cancer Centre Singapore, Singapore.

Christoph Zielinski (C)

Central European Cancer Center, Wiener Privatklinik, Vienna, and Central European Cooperative Oncology Group, HQ, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH